For those who didn't see the press release, I've included it below.
Friday November 21, 6:30 am Eastern Time
Company Press Release
SOURCE: Biopool International, Inc.
Biopool International Presents At Small-Cap Investor Conference -
Portland, Oregon
VENTURA, Calif., Nov. 21 /PRNewswire/ -- Biopool International, Inc. (Nasdaq: BIPL - news)
today announced its participation at the Red Chip Review Small- Cap
Investor Conference held November 20, 1997, in Portland, Oregon.
Biopool's chairman and chief executive officer, Michael D. Bick,
Ph.D., was on hand to present the ''Biopool Story'' to attending
investors.
Biopool International, Inc., one of twenty fast-growing,
publicly-traded small-cap companies invited to participate in this
conference, is a recognized leader and innovator in in vitro
diagnostic blood test kits used to assess and diagnose a wide range
of bleeding disorders and to evaluate and predict cardiovascular risk
factors. Biopool's core hemostasis product line (upon which the
Company was built) is believed to be the most extensive available
anywhere. The Company also develops, manufactures, and markets
specialty chemistry controls used to monitor and measure the presence
of drugs of abuse and immunohematology products used in routine ABO
and Rh blood grouping and to screen for rare antibodies and antigens
in blood.
Biopool's complete line of over 150 FDA-approved products is sold to
hospitals, clinical laboratories, commercial reference laboratories,
blood centers, and biomedical research institutions on a worldwide
basis. In addition to selling its products through distributors in
over 40 countries, many of the ''big players'' in the diagnostics
market have partnered with Biopool to utilize its manufacturing and
product development expertise.
Incorporated in Delaware in 1987 and headquartered in Ventura,
California, Biopool has two subsidiaries, Biopool AB (Sweden) and
Biopool Canada, and a newly acquired division, BCA, located in West
Chester, Pennsylvania. The acquisition of this division from Organon
Teknika Corporation in January of 1997 has effectively DOUBLED the
size of the Company as well as its expected revenues for 1997. In
fact, recently announced third quarter 1997 revenues and net
income were up 115% and 50%, respectively, over third quarter 1996!
STOCK DATA:
Symbol: BIPL
FYE: 12/31
52-Week High/Low: $3.81 - $1.93
30-Day Avg. Daily Vol.*:70,000
Float: 5.1 million (approx.)
Shares Outstanding: 8,637,664
Market Cap*: $26.4 million
10/31/97
STATEMENT OF INCOME
(in thousands, except per share data)
For Years Ended December 31, 1996 1995 1994
Sales $8,020 $6,662 $5,527
Income before taxes 1,180 261 816
Net income 1,295 141 705
Earnings per share $.15 $.02 $.09
For Nine Months Ended Sept. 30, 1997 1996
Sales $12,661 $5,873
Income before taxes 1,439 988
Net income 1,153 1,013
Earnings per share $0.13 $0.13
SOURCE: Biopool International, Inc. |
